Trials
Search / Trial NCT05654350

Lesion Site and Neglect Anosognosia in Patients With Left Hemispatial Neglect

Launched by GAZI UNIVERSITY · Dec 7, 2022

Apply for Trial

Trial Information

Current as of February 05, 2025

Completed

Keywords

Neglect Anosognosia Stroke Hemispatial Neglect Self Awareness Anosognosia

ClinConnect Summary

Babinski first defined anosognosia in 1914 as being unaware of paralysis in patients with right hemisphere stroke. Today, this term is used for the unawareness of various neurological and cognitive diseases or disabilities. One of these, anosognosia for hemispatial neglect, is an interesting phenomenon and has not been explored as thoroughly as hemiplegia anosognosia. Lesions of the right superior and inferior temporal gyrus, temporoparietal junction, and insula have been blamed for hemiplegia anosognosia. However, the neural correlates of neglect anosognosia are yet to be elucidated. There...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Being older than 18 years of age
  • • Having a subacute or chronic right hemispheric supratentorial stroke
  • • Having left hemispatial neglect
  • Exclusion Criteria:
  • • Being in the first 2 weeks of the stroke
  • • Lesions involving the left hemisphere and/or brainstem and/or cerebellum
  • • Having other neurological conditions such as traumatic brain injury, central nervous system neoplasm, neurodegenerative or neuropsychiatric diseases
  • • Presence of severe cognitive impairment in the mini-mental state examination scale (\<10 points)
  • • Lack of brain imaging data
  • • Having visual problems and psychiatric disorders hindering neglect and anosognosia evaluation

Trial Officials

Gülçin Kaymak Karataş, MD

Principal Investigator

Gazi University Faculty of Medicine

Levent Karataş, MD

Principal Investigator

Gazi University Faculty of Medicine

About Gazi University

Gazi University, a leading research institution based in Ankara, Turkey, is committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research with clinical practice to explore new therapeutic approaches and enhance existing treatments. Gazi University adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and safety of its clinical trials. By fostering partnerships with healthcare professionals and academic institutions, Gazi University aims to contribute significantly to the global scientific community and address pressing health challenges.

Locations

Ankara, , Turkey

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials